Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung Cancer

Name: Nivolumab, Cabozantinib S-Malate, and Ipilimumab in Treating Patients With Recurrent Stage IV Non-small Cell Lung Cancer
License: Public Domain

National Cancer Institute (NCI)

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

metastatic lung non-squamous non-small cell carcinoma, recurrent lung non-squamous non-small cell carcinoma, stage iv lung non-small cell cancer ajcc v7

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 417558
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.